Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents

EuroIntervention

Volumn 5, Issue 4, 2009, Pages 505-510

  Basalus, Mounir W Z ^a   Van Houwelingen, K Gert ^a   Ankone, Marc ^b   De Man, Frits H A F ^a   Von Birgelen, Clemens ^a,b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Biodegradable polymer coating; BioMatrix; Coronary artery disease; Drug eluting stent; Percutaneous coronary intervention; Scanning electron microscopy

Indexed keywords

BIOLIMUS; CARDIOVASCULAR AGENT; POLYLACTIC ACID; UNCLASSIFIED DRUG; BIOLIMUS A9; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; WATER;

ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG ELUTING STENT; ELASTICITY; MATERIAL COATING; MATERIALS TESTING; MECHANICAL TORSION; SCANNING ELECTRON MICROSCOPY; BIODEGRADABLE IMPLANT; EQUIPMENT DESIGN; GENETIC PROCEDURES; HUMAN; INSTRUMENTATION; METHODOLOGY; REPRODUCIBILITY; STATISTICS;

ABSORBABLE IMPLANTS; BIOSENSING TECHNIQUES; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICROSCOPY, ELECTRON, SCANNING; REPRODUCIBILITY OF RESULTS; SIROLIMUS; WATER;

EID: 77950493770     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV5I4A80     Document Type: Article

References (19)

1. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME (2003) Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108:788-794. (Pubitemid 37022118)
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. (Pubitemid 37186209)
3. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, Guagliumi G, Wijns W, Lindeboom WK, Ligthart J, de Feyter PJ, Morice MC. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
4. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schomig A (2007) Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356:1030-1039. (Pubitemid 46376803)
5. Schomig A, Dibra A, Windecker S, Mehilli J, Suarez de LJ, Kaiser C, Park SJ, Goy JJ, Lee JH, Di LE, Wu J, Juni P, Pfisterer ME, Meier B, Kastrati A. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 2007;50:1373-80. (Pubitemid 47449734)
6. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-97. (Pubitemid 46376799)
7. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-48. (Pubitemid 47393576)
8. Daemen J, Serruys PW. Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation 2007;116:316-28.
9. Ostojic M, Sagic D, Jung R, Zhang YL, Nedeljkovic M, Mangovski L, Stojkovic S, Debeljacki D, Colic M, Beleslin B, Milosavljevic B, Orlic D, Topic D, Karanovic N, Paunovic D, Christians U. The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study. Catheter Cardiovasc Interv 2008;72:901-8.
10. Storger H, Grube E, Hofmann M, Schwarz F, Haase J. Clinical experiences using everolimus-eluting stents in patients with coronary artery disease. J Interv Cardiol 2004;17:387-90. (Pubitemid 39552593)
11. Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, vom DJ, Bosserhoff AK, Michaeli W, Hanrath P, Weber C, Blindt R. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 2004;25:1330-40. (Pubitemid 38998510)
12. Grube E, Buellesfeld L. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices 2006;3:731-41. (Pubitemid 46017613)
13. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Davies S, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Juni P. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 2008;372:1163-73.
14. Ormiston J, Webster M, Ruygrok P, Stewart J, Scott D, Currie E, Panther M, Shaw B. Polymer integrity after Cypher and Taxus stent implantation: A scanning electron microscope study. http://www.tctmd.com. 2005.
15. Otsuka Y, Chronos NA, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol 2007;19:71-6.
16. Kitahara H, Kobayashi Y, Yamaguchi M, Fujimoto Y, Nameki M, Nakayama T, Kuroda N, Komuro I. Damage to polymer of undelivered sirolimus-eluting stents. J Invasive Cardiol 2008;20:130-3. (Pubitemid 351346274)
17. Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention 2009;5:157-165.
18. Conti JC, Strope E, Ramesh R, Conti C, Watkins A. A Comprehensive Protocol and Procedural Considerations Designed to Evaluate the Shedding of Particles from Drug Eluting Stents. Proceedings from the Materials & Processes for Medical Devices Conference, 2007.
19. von Birgelen C, Mintz GS, Bose D, Baumgart D, Haude M, Wieneke H, Neumann T, Brinkhoff J, Jasper M, Erbel R. Impact of moderate lesion calcium on mechanisms of coronary stenting as assessed with three-dimensional intravascular ultrasound in vivo. Am J Cardiol 2003;92:5-10. (Pubitemid 36782300)